Clinical Trials Directory

Trials / Completed

CompletedNCT02916966

Environmental Exposure and Neurological Diseases Questionnaire

Case-control and Population Questionnaire Studying Environmental Risk Factors and Neurological Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
460 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The proposed research is particularly relevant to the National ALS Registry and public environmental health issues because it addresses the potential environmental causes of sporadic ALS. The research will develop an ALS surveillance program in Ohio that can be compared with the national and State-Metro Surveillance Programs of the National ALS Registry, and novel methodologies to determine the role of the cyanobacterial toxin, BMAA (beta-methylamino-L-alanine), and other environmental toxins/toxicants as risk factors for ALS. This work will advance the mission of the Centers for Disease Control Agency for Toxic Substances and Disease Registry (CDC ATSDR) National ALS Registry by offering data on ALS cases in Ohio that address public health concerns over the effects of chronic exposure to cyanobacterial blooms in Lake Erie.

Conditions

Interventions

TypeNameDescription
OTHERPatient RegistryPatient Registry

Timeline

Start date
2016-10-01
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2016-09-28
Last updated
2024-05-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02916966. Inclusion in this directory is not an endorsement.